ORTHOGENRX
OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices for the treatment of musculoskeletal conditions. The business model utilizes exclusive supply and license agreements for products presently on the market ex-US and seeks generic product approval in the U.S. potentially saving the healthcare system billions in cost. The strategy utilizes existing regulations for an abbreviated regulatory approval for generic devices, analogous to generic drugs.
ORTHOGENRX
Industry:
Biotechnology Commercial Health Care Medical Device
Founded:
2012-09-10
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.orthogenrx.com
Total Employee:
11+
Status:
Active
Contact:
(215) 693-1066
Email Addresses:
[email protected]
Total Funding:
6.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Age Ventures
New Age Ventures investment in Seed Round - OrthogenRx
New Age Ventures
New Age Ventures investment in Debt Financing - OrthogenRx
New Age Ventures
New Age Ventures investment in Seed Round - OrthogenRx
New Age Ventures
New Age Ventures investment in Seed Round - OrthogenRx
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - OrthogenRx
Official Site Inspections
http://www.orthogenrx.com
- Host name: wpx.net
- IP address: 194.1.147.96
- Location: Chicago United States
- Latitude: 41.8719
- Longitude: -87.6589
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60607
More informations about "OrthogenRx"
OrthogenRx - Crunchbase Company Profile & Funding
OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices.See details»
Knee pain osteoarthritis - OrthogenRX
OrthogenRx is focused on treatments to help healthcare professionals make the most difference in knee pain caused by osteoarthritis.See details»
Avanos Medical, Inc. Announces Agreement To Acquire …
Dec 13, 2021 Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire OrthogenRx, Inc., an emerging leader in viscosupplementation …See details»
OrthogenRx - The Org
OrthogenRx, Inc. is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA). …See details»
OrthogenRx - Company Profile - Tracxn
OrthogenRx is a late stage product development organization developing generic Class III medical devices in orthopedics. The business model of the company focuses on a product …See details»
OrthogenRx - Products, Competitors, Financials, Employees, …
OrthogenRx is a late stage product development company focused on the commercialization of generic Class III orthopedic medical devices. Use the CB Insights Platform to explore …See details»
OrthogenRx - Craft
OrthogenRx has 5 employees at their 1 location and $2.65 m in total funding,. See insights on OrthogenRx including office locations, competitors, revenue, financials, executives, …See details»
OrthogenRx - Contacts, Employees, Board Members, Advisors
OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices.See details»
OrthogenRx - Overview, News & Similar companies | ZoomInfo.com
Dec 13, 2021 View OrthogenRx (www.orthogenrx.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Genvisc®850 5 regimen - Hyaluronic Acid
GenVisc 850, a 5-injection hyaluronic acid, may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologicSee details»
Avanos Medical, Inc. Announces Agreement To Acquire …
Dec 13, 2021 Avanos Medical, Inc. Announces Agreement To Acquire OrthogenRx, Inc. Intra-articular injections products enhance pain portfolio with additional treatment optionsSee details»
Avanos Support
Avanos has transitioned from orthogenrx.aspnprograms.com to harmoknee.support effective September 3rd, 2024 Click Here To RegisterSee details»
Avanos Medical, Inc. Announces Agreement To Acquire …
Dec 16, 2021 Intra-articular injections products enhance pain portfolio with additional treatment options PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered …See details»
OrthogenRx Announces 2020 Achievements - PR Newswire
Jan 21, 2021 OrthogenRx Inc. is a late-stage development company headquartered in Doylestown, it licenses, develops, and sells equivalent orthopedic medical devices at …See details»
TriVisc® 3 regimen - OA knee pain - orthogenrx.com
TriVisc, a 3-injection Hyaluronic Acid from OrthogenRx, may help relieve OA knee pain in patients who are unresponsive to non-pharmacologicSee details»
OrthogenRx Gains Speedy FDA Approval for HA Product
Oct 12, 2015 OrthogenRx announced the approval on October 8, 2015. The product is commonly injected 3-5 times weekly into the knee and, according to the company, can provide …See details»
Top 10 Companies in Viscosupplementation Market in 2024
May 2, 2024 With a commitment to research and development, Anika continues to advance its product portfolio, ensuring quality, efficacy, and patient satisfaction in the global …See details»
Customer Service - orthogenrx.com
Our staff of knowledgeable and friendly customer service representatives are ready to assist you between 9-5PM EST Customer Service Number: 267-753-6700 Email: …See details»
OrthogenRx gets $575k funding — 5 things to know
Dec 12, 2014 Here are five quick facts about the findings: 1. Ben Franklin Technology Partners approved $1.6 million funding for nine start-ups recent. OrthogenRX will receive $575,000 in …See details»
Genvisc Full Prescribing and Safety Information - OrthogenRx
GenVisc*850 is indicated for the treatment of pain in osteoarthritis (A) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple …See details»